Α. Φωτίου

1.1k citations
23 papers · 755 · h-index 14

Impact in

Papers in

    • Cancer therapeutics and mechanisms 2
    • Cancer Treatment and Pharmacology 5
    • HER2/EGFR in Cancer Research 2

Α. Φωτίου

23 papers receiving 727 citations

Peers

Α. Φωτίου
Comparison fields: 5 of 81
  • Dermatology 137
  • Pathology and Forensic Medicine 141
  • Oncology 208
  • Cell Biology 114
  • Cancer Research 97
Replace Chao-Pei Betty Chang with:
Chao-Pei Betty Chang United States
Levi Fried United States
Majken Westergaard Denmark
Eriko Aizu-Yokota Japan
Shilpak Chatterjee United States
Hubert Kasperczyk Germany
Katherine Drews‐Elger United States
Zi Wang China
Elżbieta Płuciennik Poland
W K Hong United States
Α. Φωτίου relative to Chao-Pei Betty Chang United States Chao-Pei Betty Chang's profile →
Citations per field
00.5×5.1×
Chao-Pei Betty Chang · 1×
Citations per year

Countries citing papers authored by Α. Φωτίου

Since Specialization
Citations

This map shows the geographic impact of Α. Φωτίου's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Α. Φωτίου with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Α. Φωτίου more than expected).

Fields of papers citing papers by Α. Φωτίου

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Α. Φωτίου. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Α. Φωτίου. The network helps show where Α. Φωτίου may publish in the future.

Co-authors

The 25 scholars most cited alongside Α. Φωτίου, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Α. Φωτίου Line = papers co-authored together Α. Φωτίου links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2011105
2 200176
3 200274
4 199771
5 201061
6 200954
7 200448
8 199447
9 200141
10 199939
11 201228
12 201021
13 199220
14
LATS2 is a modulator of estrogen receptor alpha.
201316
15 200913
16 198811
17 19969
18 19968
19 19867
20
Growth inhibitory activity of S12363, a novel vinca alkaloid derivative on human melanoma cell lines.
19933

About Α. Φωτίου

Α. Φωτίου is a scholar working on Molecular Biology, Oncology, Genetics, Cancer Research and Cell Biology, having authored 23 papers that have together received 755 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Estrogen and related hormone effects (5 papers), Computational Drug Discovery Methods (2 papers), Cancer therapeutics and mechanisms (2 papers), Virus-based gene therapy research (2 papers), HER2/EGFR in Cancer Research (2 papers), Cutaneous lymphoproliferative disorders research (2 papers) and Microtubule and mitosis dynamics (2 papers). The work is most often cited by research in Dermatology (137 citations), Pathology and Forensic Medicine (141 citations), Oncology (208 citations), Cell Biology (114 citations) and Cancer Research (97 citations). Α. Φωτίου has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Spyros Retsas, Eduardo Calonje, Guy Orchard, Sean Whittaker, Alison J.‐A. Woolford, Simak Ali, R. Russell‐Jones, Bruce Kidd, Julia J. Inglis and Laki Buluwela. Their work appears in journals such as European Journal of Cancer, Bioorganic & Medicinal Chemistry, Breast Cancer Research and Treatment, Nature Medicine and Planta Medica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact